In both conditions, one would hypothesized that the glucose-dependency of GLP-1 is also lost given the lack of functional K ATP channels in the first, and the concomitant hyperglycemia in the second
Three semaglutide medications are currently approved by the FDA: Wegovy is approved for weight loss treatment, and can be prescribed to adults and children 12 and older with obesity, as well as some adults with overweight who also have weight-related health problems, such as high blood pressure
When asked about the study, Novo Nordisk said it "remains confident in the benefit-risk profile of our GLP-1 medicines, when used consistent with their indications and product labeling." "Semaglutides efficacy and safety have been extensively demonstrated in people with obesity/overweight with robust evidence for improving health outcomes," the company noted in a statement to TODAY.com
Designed by experts and backed by science, Noom offers a personalized weight-loss experience that helps you build healthier habits, shift your mindset, and get lasting results